Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study

BACKGROUND: Treatment options for patients suffering from progressive forms of multiple sclerosis (MS) remain inadequate. Mast cells actively participate in the pathogenesis of MS, in part because they release large amounts of various mediators that sustain the inflammatory network. Masitinib, a sel...

Full description

Saved in:
Bibliographic Details
Main Authors: Vermersch, Patrick, Benrabah, Rabah, Schmidt, Nicolas, Zéphir, Hélène, Clavelou, Pierre, Vongsouthi, Cyrille, Dubreuil, Patrice, Moussy, Alain, Hermine, Olivier
Format: Artigo
Language:Inglês
Published: BioMed Central 2012
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3467179/
https://ncbi.nlm.nih.gov/pubmed/22691628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2377-12-36
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items